Orchid Pharma Ltd

524372

Summary

Fair Value Assessment
Overvalued (38% Premium)
Fair ValueQ1,117.77UncertaintyVery High
Close Price1,544.15Jan 21, 2025
Market Closed
1,549.70
Price Up by 5.55 | 0.36%
Previous Close
1,544.15
Day Range
1,510.75 – 1,589.95
Year Range
709.30 – 1,998.00
Bid / Ask
Market Cap
78.6 Bil
Volume / Average
13.8 k / 9.3 k
Beta (5-Year)
5.54
Shares Outstanding
50.72 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.
Contact
Sector 74A 15th Floor, Tower-1, DLF Corporate Greens, Gurugram, HR 122004
T +91 4428211000
corporate@orchidpharma.com opens in a new tab
www.orchidpharma.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Sep 30, 2024
Fiscal Year End
Mar 31, 2025
Employees
923

Key Metrics

Income Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
9.04 8.19 6.66 5.60 4.50 5.08
Revenue Growth %
20.39% 23.00% 19.00% 24.33% -6.97% -15.32%
Gross Profit
3.59 3.21 2.69 2.33 2.10 2.41
Gross Profit Margin %
39.70% 39.15% 40.35% 41.69% 46.68% 47.41%
Operating Income
0.26 0.78 0.30 -0.32 -0.50 -1.32
Operating Margin %
2.91% 9.58% 4.46% -5.80% -11.04% -25.92%
EBIT
1.13 0.92 0.87 -0.25 -0.45 -1.51
EBIT Margin %
12.45% 11.23% 13.04% -4.52% -9.92% -29.74%
EBITDA
1.47 1.25 1.42 0.62 0.64 -0.25
EBITDA Margin %
16.30% 15.28% 21.27% 11.03% 14.28% -4.95%
Net Income
1.20 0.92 0.46 -0.02 -1.17 -1.31
Net Profit Margin %
12.95% 11.25% 7.97% -10.80% -21.16% -25.80%
Basic EPS
24.08 19.06 11.35 -0.48 -28.55 -14.75
Diluted EPS
24.08 19.06 11.35 -0.48 -28.55 -14.75
Normalized EPS
24.87 20.18 0.66 -14.86 -22.07 -9.97
Dividends per Share
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
16.35 15.54 12.25 11.11 12.37 17.22
Total Liabilities
4.11 3.84 5.37 4.63 5.84 6.97
Total Debt
1.65 1.35 3.31 2.68 4.53 5.64
Total Equity
12.24 11.69 6.89 6.47 6.53 10.24
Cash And Cash Equivalents
0.04 0.04 0.23 0.04 0.16 0.90
Working Capital
5.52 5.31 1.29 2.09 4.08 4.06
Shares Outstanding (Bil)
0.05 0.05 0.04 0.04
Book Value Per Share
241.38 217.06 151.92 141.81 143.16 234.17
Debt To Equity
0.13 0.12 0.48 0.41 0.69 0.55
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.15 1.26 0.18 0.92 0.24 0.81
Cash From Investing Activities
-0.43 -3.12 -0.31 1.13 0.67 1.67
Cash From Financing Activities
-0.08 1.67 0.31 -2.17 -1.65 -2.50
Capital Expenditures
0.82 0.65 0.85 0.14 0.01 0.04
Free Cash Flow
0.58 0.53 -0.20 -0.14 0.20 0.14
Change in Cash
-0.36 -0.19 0.18 -0.11 -0.74 -0.02

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
Quant Small Cap Gr 6.83 2.35 3,465,947
Dec 31, 2024
Invesco India Contra Gr Not Rated 2.64 1.33 1,339,039
Dec 31, 2024
Nippon India Pharma Gr Not Rated 1.23 1.26 623,032
Dec 31, 2024
Invesco India Smallcap Reg Gr 0.70 1.02 355,678
16,421
4.84%
Dec 31, 2024
UTI Small Cap Reg Gr 0.68 1.32 345,298
Dec 31, 2024
Total (for Top 5) 12.08 6,128,994
16,421

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top